Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Temporal and Spatial Post-Transcriptional Regulation of Zebrafish tie1 mRNA by Long Noncoding RNA During Brain Vascular Assembly.

Chowdhury TA, Koceja C, Eisa-Beygi S, Kleinstiver BP, Kumar SN, Lin CW, Li K, Prabhudesai S, Joung JK, Ramchandran R.

Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1562-1575. doi: 10.1161/ATVBAHA.118.310848. Epub 2018 May 3.

PMID:
29724820
2.

High cytoplasmic HuR expression is associated with advanced pT stage, high grade and increased microvessel density in urothelial bladder carcinoma.

Fus ŁP, Pihowicz P, Koperski Ł, Marczewska JM, Górnicka B.

Ann Diagn Pathol. 2018 Apr;33:40-44. doi: 10.1016/j.anndiagpath.2017.12.002. Epub 2017 Dec 13.

PMID:
29566946
3.

The RNA-binding protein HuR inhibits expression of CCL5 and limits recruitment of macrophages into tumors.

Brauß TF, Winslow S, Lampe S, Scholz A, Weigert A, Dehne N, von Stedingk K, Schmid T, Brüne B.

Mol Carcinog. 2017 Dec;56(12):2620-2629. doi: 10.1002/mc.22706. Epub 2017 Jul 28.

PMID:
28731284
4.

Reconstitution of HuR-Inhibited CUGBP1 Expression Protects Cardiomyocytes from Acute Myocardial Infarction-Induced Injury.

Gu L, Wang H, Wang J, Guo Y, Tang Y, Mao Y, Chen L, Lou H, Ji G.

Antioxid Redox Signal. 2017 Nov 10;27(14):1013-1026. doi: 10.1089/ars.2016.6880. Epub 2017 Mar 28.

PMID:
28350193
5.

Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder Cancer.

Matsuo T, Miyata Y, Asai A, Sagara Y, Furusato B, Fukuoka J, Sakai H.

PLoS One. 2017 Jan 31;12(1):e0171091. doi: 10.1371/journal.pone.0171091. eCollection 2017.

6.

Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis.

Blanco FF, Preet R, Aguado A, Vishwakarma V, Stevens LE, Vyas A, Padhye S, Xu L, Weir SJ, Anant S, Meisner-Kober N, Brody JR, Dixon DA.

Oncotarget. 2016 Nov 8;7(45):74043-74058. doi: 10.18632/oncotarget.12189.

7.

Dysregulation of TTP and HuR plays an important role in cancers.

Wang H, Ding N, Guo J, Xia J, Ruan Y.

Tumour Biol. 2016 Nov;37(11):14451-14461. Epub 2016 Sep 19. Review.

PMID:
27644249
8.

Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.

Stellos K, Gatsiou A, Stamatelopoulos K, Perisic Matic L, John D, Lunella FF, Jaé N, Rossbach O, Amrhein C, Sigala F, Boon RA, Fürtig B, Manavski Y, You X, Uchida S, Keller T, Boeckel JN, Franco-Cereceda A, Maegdefessel L, Chen W, Schwalbe H, Bindereif A, Eriksson P, Hedin U, Zeiher AM, Dimmeler S.

Nat Med. 2016 Oct;22(10):1140-1150. doi: 10.1038/nm.4172. Epub 2016 Sep 5.

PMID:
27595325
9.

MiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma.

Lo Dico A, Costa V, Martelli C, Diceglie C, Rajata F, Rizzo A, Mancone C, Tripodi M, Ottobrini L, Alessandro R, Conigliaro A.

Theranostics. 2016 May 8;6(8):1105-18. doi: 10.7150/thno.14700. eCollection 2016.

10.

MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.

Yang W, Yu H, Shen Y, Liu Y, Yang Z, Sun T.

Oncotarget. 2016 Jul 5;7(27):41505-41526. doi: 10.18632/oncotarget.9214.

11.

Induction of VEGFA mRNA translation by CoCl2 mediated by HuR.

Osera C, Martindale JL, Amadio M, Kim J, Yang X, Moad CA, Indig FE, Govoni S, Abdelmohsen K, Gorospe M, Pascale A.

RNA Biol. 2015;12(10):1121-30. doi: 10.1080/15476286.2015.1085276. Epub 2015 Sep 1.

12.

Cryptotanshinone, a novel tumor angiogenesis inhibitor, destabilizes tumor necrosis factor-α mRNA via decreasing nuclear-cytoplasmic translocation of RNA-binding protein HuR.

Zhu Z, Zhao Y, Li J, Tao L, Shi P, Wei Z, Sheng X, Shen D, Liu Z, Zhou L, Tian C, Fan F, Shen C, Zhu P, Wang A, Chen W, Zhao Q, Lu Y.

Mol Carcinog. 2016 Oct;55(10):1399-410. doi: 10.1002/mc.22383. Epub 2015 Aug 27.

PMID:
26310813
13.

RNA-stabilizing proteins as molecular targets in cardiovascular pathologies.

Suresh Babu S, Joladarashi D, Jeyabal P, Thandavarayan RA, Krishnamurthy P.

Trends Cardiovasc Med. 2015 Nov;25(8):676-83. doi: 10.1016/j.tcm.2015.02.006. Epub 2015 Feb 20. Review.

14.

ELAVL1 modulates transcriptome-wide miRNA binding in murine macrophages.

Lu YC, Chang SH, Hafner M, Li X, Tuschl T, Elemento O, Hla T.

Cell Rep. 2014 Dec 24;9(6):2330-43. doi: 10.1016/j.celrep.2014.11.030. Epub 2014 Dec 18.

15.

Chemopreventive apigenin controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1.

Tong X, Mirzoeva S, Veliceasa D, Bridgeman BB, Fitchev P, Cornwell ML, Crawford SE, Pelling JC, Volpert OV.

Oncotarget. 2014 Nov 30;5(22):11413-27.

16.

ELAVL1 regulates alternative splicing of eIF4E transporter to promote postnatal angiogenesis.

Chang SH, Elemento O, Zhang J, Zhuang ZW, Simons M, Hla T.

Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18309-14. doi: 10.1073/pnas.1412172111. Epub 2014 Nov 24.

17.

HuR: a promising therapeutic target for angiogenesis.

Dong R, Yang GD, Luo NA, Qu YQ.

Gland Surg. 2014 Aug;3(3):203-6. doi: 10.3978/j.issn.2227-684X.2014.03.02. Review.

18.

Post-transcriptional gene regulation by HuR and microRNAs in angiogenesis.

Chang SH, Hla T.

Curr Opin Hematol. 2014 May;21(3):235-40. doi: 10.1097/MOH.0000000000000040. Review.

PMID:
24714527
19.

Control of pro-angiogenic cytokine mRNA half-life in cancer: the role of AU-rich elements and associated proteins.

Griseri P, Pagès G.

J Interferon Cytokine Res. 2014 Apr;34(4):242-54. doi: 10.1089/jir.2013.0140. Review.

PMID:
24697202
20.

HuR and other turnover- and translation-regulatory RNA-binding proteins: implications for the kidney.

Pullmann R Jr, Rabb H.

Am J Physiol Renal Physiol. 2014 Mar 15;306(6):F569-76. doi: 10.1152/ajprenal.00270.2013. Epub 2014 Jan 15. Review.

Supplemental Content

Loading ...
Support Center